Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 08:20:49 GMT 2025
by
admin
on
Wed Apr 02 08:20:49 GMT 2025
|
| Protein Type | COAGULATION FACTOR |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Record UNII |
27Y83O992Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
276509
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9338
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
PRIMARY | |||
|
C166552
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
PRIMARY | |||
|
100000166586
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108348
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
PRIMARY | |||
|
SUB180810
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
PRIMARY | |||
|
1990855
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
PRIMARY | |||
|
1175512-71-6
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
PRIMARY | |||
|
27Y83O992Q
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
PRIMARY | |||
|
DB13933
Created by
admin on Wed Apr 02 08:20:49 GMT 2025 , Edited by admin on Wed Apr 02 08:20:49 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_18 | 1_23 |
| 1_51 | 1_62 |
| 1_56 | 1_71 |
| 1_73 | 1_82 |
| 1_88 | 1_99 |
| 1_95 | 1_109 |
| 1_111 | 1_124 |
| 1_132 | 1_289 |
| 1_206 | 1_222 |
| 1_336 | 1_350 |
| 1_361 | 1_389 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_157 |
| N | 1_167 |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_7] [1_8] [1_15] [1_17] [1_20] [1_21] [1_26] [1_27] [1_33] [1_36] [1_40] | SITE_SPECIFIC | .GAMMA.-CARBOXYGLUTAMIC ACID | 16FQV4RZKL | ||
| PEGYLATION | [1_157] [1_167] | SITE_SPECIFIC |
Amount:
|
UNSPECIFIED SUBSTANCE |
fe8f058d
(not in database)
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|